Methods of treating musculoskeletal deformities in quadruped animals

a quadruped animal and musculoskeletal technology, applied in the direction of muscular disorders, drug compositions, peptide/protein ingredients, etc., can solve the problems of marked decrease in the monetary value and functional use of an animal, lameness and even euthanasia, and limited data regarding the degree of post-surgical function and long-term effects

Pending Publication Date: 2022-06-30
VETMED THERAPEUTICS INC
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention is about treating muscle abnormalities in horses and other animals by injecting them with a type of toxin called botulinum toxin. This can help reduce the severity of abnormalities and the debilitation they cause. Specifically, the invention focuses on treating flexural, angular, and rotational abnormalities in the legs and shoulders of young hooved animals. The method can effectively treat these abnormalities, potentially eliminating the need for surgery.

Problems solved by technology

Limb abnormalities of the foal are a common malady that markedly decreases the monetary value and functional use of an animal, such as a horse.
Particularly severe deformities if uncorrected can lead to lameness and even euthanasia.
Reports indicate that horses subjected to the procedure are able to perform, but data is limited regarding the degree of post-surgical function and the long-term effects.
The current treatments do not address the effect of the myotatic reflex which determines the vertical loading of the limb and its component joints, growth plates and bones.
Intervention for rotational anomalies is poorly substantiated by research and currently includes foot trimming, shoes with extensions and orthopedic surgical intervention.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

Deformity

[0045]A 3 month old walking horse colt that had developed an increased pastern angle bilaterally. The colt was otherwise healthy with no other evidence of leg disease or discomfort. He was beginning to exhibit changes in shape of his hoof including the development of a more cylindrical hoof.

[0046]50 U of Botox® botulinum toxin type A was divided into the bilateral superficial digital flexor muscles. 12.5 U aliquots were administered through 4 injections at 4 sites on each side.

[0047]The horse tolerated the procedure well with no adverse effects noted. The horse was monitored daily showing no signs of adverse effects. The pastern angle stabilized and the horse remains functional with steep pastern angles and low heels.

example 2

Deformity

[0048]A one-year old thoroughbred colt exhibited normal orthopedic development until approximately 6 months of age when he exhibited a steepening of the pastern angle associated with posterior displacement of the knee. Examination showed no other abnormalities.

[0049]The horse received a total of 200 U of Botox® botulinum toxin type A administered in 25 unit aliquots divided evenly between the bilateral deep digital flexor muscles (DDF). The horse tolerated the procedure well with no adverse effects noted. At 2 weeks post injection, no further deterioration was observed. The horse entered race training and has performed in normal duties.

example 3

Deformity

[0050]A four-month old thoroughbred filly developed an increasing pastern angle, increased hoof angle, and “back in the knee” unilaterally. The horse was otherwise healthy with no evidence of underlying hoof or leg disease.

[0051]The filly received 75 U of Botox® botulinum toxin type A in the DDF. This was administered in 25 U aliquots at 3 injection sites in the DDF. The horse tolerated the procedure well with no adverse effects noted. At two weeks post injection the filly showed no deterioration in orthopedic alignment and no gait abnormalities. At 8 months of age the angles had returned to a normal conformation. The filly is currently in race training.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Methods of treating musculoskeletal deformities of an anatomical structure in a quadruped animal with botulinum toxin are described. Such deformities can be rotational or flexural. Such deformities can be acquired or congenital. Such anatomical structures include a limb, neck, torso, and / or pelvis of the quadruped animal.

Description

FIELD OF THE INVENTION[0001]The invention relates to the treatment of musculoskeletal abnormalities in quadruped animals with botulinum toxin. More particularly, the method is effective in treating musculoskeletal abnormalities in the limb of a quadruped animal, such as hooved animals and other quadrupeds that are less than 3 years old.BACKGROUND OF THE INVENTION[0002]Limb abnormalities of the foal are a common malady that markedly decreases the monetary value and functional use of an animal, such as a horse. These conditions can be present at birth or may develop shortly thereafter. These conditions are generally divided into three categories, namely, flexural, angular and rotational dysfunction, noting that some conditions can be more than one type. Particularly severe deformities if uncorrected can lead to lameness and even euthanasia.[0003]Flexural abnormalities refer to hyperextension (e.g., “back-at-the-knee” and “dropped fetlock”) and hyperflexion (the inability to fully exte...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/48A61K9/00A61P21/00
CPCA61K38/4893A61P21/00A61K9/0019C12Y304/24069A61K39/08A61P19/00
Inventor RENFROE, J. BENCARTER, DANIEL W.
Owner VETMED THERAPEUTICS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products